Actively Recruiting
M-ARS ACL Post-marketing Surveillance Study
Led by Medacta International SA · Updated on 2023-03-13
200
Participants Needed
3
Research Sites
235 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The goal of this study is to evaluate the performance of Medacta Anatomic Ribbon Surgery (M-ARS) in patients requiring anterior cruciate ligament (ACL) reconstruction. The main goal is to evaluate the survival rate of M-ARS ACL at 6 months post-operatively. The secondary goals are to assess the survival rate, clinical and functional outcomes, the quality of life, and the rate of complications at 1 month, 1 year and 2 years post-operatively.
CONDITIONS
Official Title
M-ARS ACL Post-marketing Surveillance Study
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients older than 18 years
- Patients with ACL rupture requiring ACL reconstruction
You will not qualify if you...
- Patients with malignant diseases at the time of surgery
- Patients with proven or suspected infections at the time of surgery
- Patients with functional deficits of the affected extremity at the time of surgery
- Patients with known incompatibility or allergy to product materials at the time of surgery
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 3 locations
1
Praxis Gelenkpunkt - Sport- und Gelenkchirurgie
Innsbruck, Austria, 6020
Actively Recruiting
2
Pyhrn-Eisenwurzen Klinikum Kirchdorf
Kirchdorf an der Krems, Austria, 4560
Actively Recruiting
3
OCM Klinik GmbH
München, Germany, 81369
Actively Recruiting
Research Team
D
Denise Falcone
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here